194 related articles for article (PubMed ID: 8650201)
21. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
[TBL] [Abstract][Full Text] [Related]
22. Expression profile of tyrosine kinases in breast cancer.
Meric F; Lee WP; Sahin A; Zhang H; Kung HJ; Hung MC
Clin Cancer Res; 2002 Feb; 8(2):361-7. PubMed ID: 11839650
[TBL] [Abstract][Full Text] [Related]
23. Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor.
Knighton DR; Cadena DL; Zheng J; Ten Eyck LF; Taylor SS; Sowadski JM; Gill GN
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5001-5. PubMed ID: 8389462
[TBL] [Abstract][Full Text] [Related]
24. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.
Adam RM; Borer JG; Williams J; Eastham JA; Loughlin KR; Freeman MR
Endocrinology; 1999 Dec; 140(12):5866-75. PubMed ID: 10579352
[TBL] [Abstract][Full Text] [Related]
25. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.
Shen R; Su ZZ; Olsson CA; Fisher PB
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6778-82. PubMed ID: 7542776
[TBL] [Abstract][Full Text] [Related]
26. Epidermal Growth Factor Receptor Tyrosine Kinase: A Potential Target in Treatment of Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj N
J Environ Pathol Toxicol Oncol; 2017; 36(2):151-158. PubMed ID: 29199595
[TBL] [Abstract][Full Text] [Related]
27. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
28. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2.
Tamagnone L; Lahtinen I; Mustonen T; Virtaneva K; Francis F; Muscatelli F; Alitalo R; Smith CI; Larsson C; Alitalo K
Oncogene; 1994 Dec; 9(12):3683-8. PubMed ID: 7970727
[TBL] [Abstract][Full Text] [Related]
29. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.
Kraus MH; Fedi P; Starks V; Muraro R; Aaronson SA
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2900-4. PubMed ID: 8464905
[TBL] [Abstract][Full Text] [Related]
30. cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain.
Tang XX; Biegel JA; Nycum LM; Yoshioka A; Brodeur GM; Pleasure DE; Ikegaki N
Genomics; 1995 Sep; 29(2):426-37. PubMed ID: 8666391
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.
Lee H; Maihle NJ
Oncogene; 1998 Jun; 16(25):3243-52. PubMed ID: 9681822
[TBL] [Abstract][Full Text] [Related]
32. Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells.
Kim O; Jiang T; Xie Y; Guo Z; Chen H; Qiu Y
Oncogene; 2004 Mar; 23(10):1838-44. PubMed ID: 14981536
[TBL] [Abstract][Full Text] [Related]
33. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation.
Raab M; Cai YC; Bunnell SC; Heyeck SD; Berg LJ; Rudd CE
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8891-5. PubMed ID: 7568038
[TBL] [Abstract][Full Text] [Related]
34. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.
Wainstein MA; He F; Robinson D; Kung HJ; Schwartz S; Giaconia JM; Edgehouse NL; Pretlow TP; Bodner DR; Kursh ED
Cancer Res; 1994 Dec; 54(23):6049-52. PubMed ID: 7525052
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.
Plowman GD; Whitney GS; Neubauer MG; Green JM; McDonald VL; Todaro GJ; Shoyab M
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):4905-9. PubMed ID: 2164210
[TBL] [Abstract][Full Text] [Related]
36. Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases.
Singh J; Dobrusin EM; Fry DW; Haske T; Whitty A; McNamara DJ
J Med Chem; 1997 Mar; 40(7):1130-5. PubMed ID: 9089334
[TBL] [Abstract][Full Text] [Related]
37. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.
Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY
Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103
[TBL] [Abstract][Full Text] [Related]
38. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
39. The c-erbB-2 gene encodes a receptor-like protein with tyrosine kinase activity.
Toyoshima K; Semba K; Akiyama T; Ikawa S; Yamamoto T
Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():977-82. PubMed ID: 3472771
[No Abstract] [Full Text] [Related]
40. ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma.
Gunes S; Sullu Y; Yegin Z; Buyukalpelli R; Tomak L; Bagci H
Pathol Res Pract; 2013 Feb; 209(2):99-104. PubMed ID: 23333248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
